Back to search

Article

Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UK

2022-02-15

Abstract excerpt

<h4>Background: </h4> Fremanezumab is an anti-calcitonin gene-related peptide monoclonal antibody efficacious for chronic migraine prophylaxis. We evaluated real-world prophylactic efficacy of fremanezumab for refractory chronic migraine in a United Kingdom specialist centre (Hull Migraine Clinic). <h4>Methods: </h4>: 289 adult chronic migraineurs commenced fremanezumab with prospective follow-up, maintaining head...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e3569bb-3fdd-5af3-ae05-cdc7435740ea
DOI
10.21203/rs.3.rs-1340639/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKDOI 10.21203/rs.3.rs-1340639/v1
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity
Galcanezumab Add-on in Refractory Cluster HeadacheSemantic proximity
Safety and Efficacy of Fremanezumab for the Prevention of Migraine: a Meta-analysis from Random Clinical TrailsSemantic proximity
Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic ReviewSemantic proximity
Real-world Evidence Data on the Monoclonal Antibody Erenumab in Migraine Prevention: Perspectives of Treating Physicians in GermanySemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).Semantic proximity
Reduction of pain and functional disability over time in patients treated with zavegepant: A Post-hoc analysis of the BHV3500-301 Phase 3 Randomized Controlled TrialSemantic proximity
Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity
Select a neighboring publication to make it the new centre.